Unlock instant, AI-driven research and patent intelligence for your innovation.

Polypeptide composition and application thereof

A technology of polypeptide composition and composition, which is applied in the direction of active ingredients, applications, and animal repellents of hydroxyl compounds, which can solve problems such as inability to represent synergistic effects, achieve broad commercial application prospects, save costs, and facilitate transportation

Pending Publication Date: 2022-07-01
GENLOCI BIOTECH
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] However, this document only discloses the synergistic effect of two antibacterial ingredients on a certain bacterium, which does not mean that the combined use of two antibacterial substances has a synergistic effect on all bacteria
Disclosed as Theansungnoen T etc. After the combination of lysozyme and crocodile leukocyte extract, there is no synergistic effect on Bifidobacterium brevis, but it has a better synergistic effect on Vibrio cholerae (Theansungnoen T, Tastub P, Jangpromma N, et al. al.Antimicrobial efficacy of a combination of crocodile (Crocodylus siamensis) leukocyte extract and hen egglysozyme[J].Chiang Mai Journal of Science, 2018,45(2):797-810.); Cao, Y etc. disclosed the antimicrobial peptide ZXR- 2.3 Combination with antimicrobial peptide KT2 has no synergistic effect on Streptococcus mutans, while antimicrobial peptide ZXR-2.3 combined with broad-spectrum anti-biofilm peptide IDR-1018 has synergistic effect on Streptococcus mutans (Cao, Y., Yin, H .,Wang,W.etal.Killing Streptococcus mutans in mature biofilm with a combination of antimicrobial and antibiofilm peptides[J].Amino Acids,2020,52(1):1-14.)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Polypeptide composition and application thereof
  • Polypeptide composition and application thereof
  • Polypeptide composition and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] Example 1 Anti-Escherichia coli Performance Test of Polypeptide and Ethanol Compounding

[0040] Fractional inhibitory concentration (FIC) index is one of the parameters of antibacterial pharmacodynamics (PD), which is the combined drug susceptibility of two antibacterial drugs. Irrelevance and addition of four cases.

[0041] Calculation of FIC index: FIC index=MIC(group A combined) / MIC(group A used alone)+MIC(group B combined) / MIC(group B used alone).

[0042] FIC index interpretation standard: when the FIC index is ≤0.5, the two drugs are synergistic; when the FIC index is 0.5-1, the two drugs are additive; when the FIC index is 1-2, the two drugs are irrelevant Effect; when the FIC index>2, the two drugs are antagonistic.

[0043] Since both peptides and ethanol are antibacterial substances, the FIC index was selected to evaluate the effect of the two compounds.

[0044] Operate according to the provisions of 2.1.8.4 of the Technical Specification for Disinfectio...

Embodiment 2

[0054] Embodiment 2 Polypeptide and ethanol compound anti-Staphylococcus aureus performance test

[0055] Dilute the polypeptide with sterile ultrapure water to the concentration of 0mg / L, 12.5mg / L, 25mg / L, 50mg / L, 100mg / L, 150mg / L, 200mg / L, 300mg / L, ethanol with sterile Ultrapure water was diluted to the concentration of 0%, 1%, 3%, 6%, 9%, 12%, 15%, 18%, 21%, 24%, and 50 μL of the above-mentioned different concentrations of polypeptide and ethanol concentration were taken, Put it in a 96-well plate, add 100 μL of Escherichia coli bacterial suspension to each well, and set positive and negative controls, wherein the positive control is 100 μL sterile water + 100 μL bacterial suspension; the negative control is 100 μL sterile water +100 μL sterile (2X) LB medium. The experiment was set up in two parallels, named group 3 and group 4.

[0056] The 96-well plate was placed in a 37±2°C incubator for 48 hours, and the results were observed.

[0057] When the positive control has...

Embodiment 3

[0062] Example 3 Anti-Bacillus subtilis performance test of polypeptide and ethanol

[0063] Operate according to the provisions of 2.1.8.4 of the Technical Specification for Disinfection (2002).

[0064] Preparation of bacterial suspension: take the activated bacterial liquid, adjust the OD value, and make the initial bacterial suspension, so that the OD600 of the Bacillus subtilis bacterial liquid is 0.8, and the corresponding bacterial liquid concentration is about 10. 8 cfu / mL, then diluted with (2X) LB medium to a concentration of 5.0×10 5 -5.0×10 6 cfu / mL as the test bacteria suspension.

[0065] Dilute the polypeptide and ethanol with sterile ultrapure water into test solutions of different concentrations, add 50 μL of each to the 96-well plate, and then add 100 μL of the diluted bacterial suspension.

[0066] Dilute the peptide with sterile ultrapure water to the concentration of 0mg / L, 0.2mg / L, 0.39mg / L, 0.78mg / L, 1.56mg / L, 3.13mg / L, 6.25mg / L, 12.5mg / L. L, 25mg / L,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of biology, in particular to a polypeptide composition and application thereof, and the composition is prepared by taking polypeptide and low-concentration ethanol as main components and adding auxiliary materials or auxiliary components. The invention also discloses an application of the composition in microorganisms, and the composition has obvious antibacterial and bacteriostatic effects. Compared with the prior art, the polypeptide and the low-concentration ethanol can have a synergistic effect after being compounded, the respective use concentration is reduced, the antibacterial effect is not reduced, the safety is high, hormone and antibiotics are avoided, meanwhile, the composition of the polypeptide and the low-concentration ethanol can effectively reduce the use concentration of the polypeptide, the cost is saved, and the application prospect is wide. And low-concentration ethanol is also convenient to transport, so that the method has a relatively good market application prospect.

Description

technical field [0001] The present invention relates to the field of biotechnology, in particular to a polypeptide composition and use thereof. Background technique [0002] The demand for disinfection products is increasing day by day. The common disinfection products in the market are mostly chemical products. While disinfection and sterilization, it will also bring some problems such as stimulating the respiratory system, stimulating the skin, mixing harmful substances, and producing resistant bacteria, etc. Adverse effects, of which ethanol is the most common, commonly used and efficient, fast broad-spectrum fungicide. [0003] The antibacterial effect of ethanol is non-specific, mainly denaturing and coagulating proteins, lysing cells, thereby disrupting cell metabolism and making microorganisms unable to survive. Disinfectants with ethanol as the main component on the market include Dr. Xiao skin disinfectant, Purui Lai hand sanitizer, Dettol hand sanitizer and so on....

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/10A61K31/045A61P31/04A61K8/64A61K8/34A61Q17/00A01N37/46A01N31/02A01P1/00
CPCA61K38/10A61K31/045A61P31/04A61K8/64A61K8/34A61Q17/005A01N37/46A01N31/02A61K2300/00
Inventor 凌建群余海赵玲江文娟
Owner GENLOCI BIOTECH